Arkolith/Insider Trading/RSLS/Form 4

Stankovich Thomas

Chief Financial OfficerReShape Lifesciences Inc. (RSLS) · full profile →Form 4 · filed Jul 6, 2023
Net Buying
Open-Market Buys
$27K
Open-Market Sells
$746
Net Open-Market Flow
$26K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2023Buy(P)18K$1.52$27K23K
May 31, 2023Sell(S)98$2.41$2366K
Apr 30, 2023Sell(S)96$2.36$2276K
Mar 31, 2023Sell(S)109$2.60$2836K

Transaction Codes

P
Open-market purchase
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001235802-23-000075) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML